I 
109TH CONGRESS 
1ST SESSION 
H. R. 810
To amend the Public Health Service Act to provide for human embryonic 
stem cell research. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 15, 2005
Mr. CASTLE (for himself, Ms. DEGETTE, Mr. BASS, Mr. DINGELL, Mr. 
FOLEY, Mr. WAXMAN, Mrs. BONO, Mr. STARK, Mr. TOM DAVIS of Vir-
ginia, Mr. CUMMINGS, Mr. KIRK, Ms. SLAUGHTER, Mrs. KELLY, Mr. 
EVANS, Mr. SHAYS, Mr. RANGEL, Mr. SIMMONS, Mr. CONYERS, Mr. 
BOEHLERT, Mr. LANGEVIN, Mr. SCHWARZ of Michigan, Mr. UDALL of 
Colorado, Mr. GIBBONS, Ms. BALDWIN, Mr. GILCHREST, Ms. PELOSI, 
Mr. PORTER, Mr. ABERCROMBIE, Mr. RAMSTAD, Mr. ACKERMAN, Mr. 
ALLEN, Mr. ANDREWS, Ms. BEAN, Mr. BECERRA, Ms. BERKLEY, Mr. 
BERMAN, Mrs. BIGGERT, Mr. BISHOP of Georgia, Mr. BISHOP of New 
York, Mr. BLUMENAUER, Mr. BOSWELL, Mr. BOUCHER, Mr. BRADLEY 
of New Hampshire, Mr. BROWN of Ohio, Mr. BUTTERFIELD, Mrs. 
CAPPS, Mr. CAPUANO, Mr. CARDIN, Mr. CARNAHAN, Ms. CARSON, Mr. 
CASE, Mrs. CHRISTENSEN, Mr. CLAY, Mr. CLEAVER, Mr. COOPER, Mr. 
CROWLEY, Mr. DAVIS of Alabama, Mr. DAVIS of Illinois, Mr. DAVIS of 
Florida, Mrs. DAVIS of California, Mr. DEFAZIO, Ms. DELAURO, Mr. 
DICKS, Mr. DOGGETT, Mr. EMANUEL, Mr. ENGEL, Ms. ESHOO, Mr. 
FARR, Mr. FILNER, Mr. FORD, Mr. FRANK of Massachusetts, Mr. GOR-
DON, Mr. AL GREEN of Texas, Mr. GENE GREEN of Texas, Mr. 
GRIJALVA, Mr. GUTIERREZ, Ms. HARMAN, Ms. HERSETH, Mr. HIGGINS, 
Mr. HINCHEY, Mr. HONDA, Ms. HOOLEY, Mr. HOLT, Mr. HOYER, Mr. 
INSLEE, Mr. ISRAEL, Mr. JACKSON of Illinois, Ms. JACKSON-LEE of 
Texas, Ms. EDDIE BERNICE JOHNSON of Texas, Mr. KENNEDY of Rhode 
Island, Ms. KILPATRICK of Michigan, Mr. KIND, Mr. KOLBE, Mr. LAN-
TOS, Mr. LARSEN of Washington, Mr. LARSON of Connecticut, Mr. 
LEACH, Ms. LEE, Mr. LEVIN, Mr. LEWIS of Georgia, Ms. ZOE LOFGREN 
of California, Mrs. LOWEY, Mrs. MALONEY, Mr. MARKEY, Mr. MATHE-
SON, Mrs. MCCARTHY, Ms. MCCOLLUM of Minnesota, Mr. MCDERMOTT, 
Mr. MCGOVERN, Mr. MEEHAN, Mr. MENENDEZ, Mr. GEORGE MILLER 
of California, Mr. MOORE of Kansas, Mr. MORAN of Virginia, Mr. NAD-
LER, Mrs. NAPOLITANO, Mr. NEAL of Massachusetts, Ms. NORTON, Mr. 
OLVER, Mr. OWENS, Mr. PALLONE, Mr. PASCRELL, Mr. PASTOR, Mr. 
PAYNE, Mr. PRICE of North Carolina, Mr. REYES, Mr. ROSS, Mr. ROTH-
MAN, Mr. RUPPERSBERGER, Mr. RUSH, Mr. SABO, Ms. LINDA T.
SA´NCHEZ of California, Ms. LORETTA SANCHEZ of California, Ms. 
SCHAKOWSKY, Mr. SCHIFF, Ms. SCHWARTZ of Pennsylvania, Mr. SHER-
MAN, Mr. SMITH of Washington, Mr. SNYDER, Ms. SOLIS, Mr. SPRATT, 
Mr. STRICKLAND, Mrs. TAUSCHER, Mr. THOMPSON of Mississippi, Mr. 
TOWNS, Mr. VAN HOLLEN, Mr. VISCLOSKY, Ms. WATERS, Ms. WATSON, 
Mr. WEINER, Mr. WEXLER, Ms. WOOLSEY, Mr. WU, Mr. WYNN, and Mr. 
DENT) introduced the following bill; which was referred to the Committee 
on Energy and Commerce 
A BILL 
To amend the Public Health Service Act to provide for 
human embryonic stem cell research.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Stem Cell Research 
Enhancement Act of 2005’’. 
SEC. 2. HUMAN EMBRYONIC STEM CELL RESEARCH. 
Part H of title IV of the Public Health Service Act 
(42 U.S.C. 289 et seq.) is amended by inserting after sec-
tion 498C the following: 
‘‘SEC. 498D. HUMAN EMBRYONIC STEM CELL RESEARCH. 
‘‘(a) IN GENERAL.—Notwithstanding any other pro-
vision of law (including any regulation or guidance), the 
Secretary shall conduct and support research that utilizes 
human embryonic stem cells in accordance with this sec-
tion (regardless of the date on which the stem cells were 
derived from a human embryo) .
‘‘(b) ETHICAL REQUIREMENTS.—Human embryonic 
stem cells shall be eligible for use in any research con-
ducted or supported by the Secretary if the cells meet each 
of the following: 
‘‘(1) The stem cells were derived from human 
embryos that have been donated from in vitro fer-
tilization clinics, were created for the purposes of 
fertility treatment, and were in excess of the clinical 
need of the individuals seeking such treatment. 
‘‘(2) Prior to the consideration of embryo dona-
tion and through consultation with the individuals 
seeking fertility treatment, it was determined that 
the embryos would never be implanted in a woman 
and would otherwise be discarded. 
‘‘(3) The individuals seeking fertility treatment 
donated the embryos with written informed consent 
and without receiving any financial or other induce-
ments to make the donation. 
‘‘(c) GUIDELINES.—Not later than 60 days after the 
date of the enactment of this section, the Secretary, in 
consultation with the Director of NIH, shall issue final 
guidelines to carry out this section. 
‘‘(d) REPORTING REQUIREMENTS.—The Secretary 
shall annually prepare and submit to the appropriate com-
mittees of the Congress a report describing the activities
carried out under this section during the preceding fiscal 
year, and including a description of whether and to what 
extent research under subsection (a) has been conducted 
in accordance with this section.’’.
Æ